CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-27 | Adams Brian General Counsel | Sale | −293 | $36.87 | $11K | 25,284 |
| 2021-09-13 | Adams Brian General Counsel | Option exercise | +6,500 | $4.12 | $27K | 32,077 |
| 2021-09-13 | Adams Brian General Counsel | Sale | −6,500 | $35.02 | $228K | 25,577 |
| 2021-09-13 | Adams Brian General Counsel | Option exercise · Stock Option (Right to Buy) | −6,500 | 147,286 | ||
| 2021-09-13 | Catinazzo Thomas Senior Vice President, Finance | Option exercise | +22,500 | $4.12 | $93K | 38,077 |
| 2021-09-13 | Catinazzo Thomas Senior Vice President, Finance | Sale | −22,500 | $35.00 | $788K | 15,577 |
| 2021-09-13 | Catinazzo Thomas Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −22,500 | 62,043 | ||
| 2021-06-28 | Adams Brian General Counsel | Sale | −293 | $35.81 | $10K | 25,577 |
| 2021-06-28 | Catinazzo Thomas Senior Vice President, Finance | Sale | −293 | $35.81 | $10K | 15,577 |
| 2021-06-28 | Bergstrom Donald A See Remarks | Sale | −976 | $35.81 | $35K | 76,265 |
| 2021-06-16 | Bergstrom Donald A See Remarks | Option exercise | +42,242 | $4.12 | $174K | 119,483 |
| 2021-06-16 | Bergstrom Donald A See Remarks | Sale | −42,242 | $33.75 | $1.4M | 77,241 |
| 2021-06-16 | Bergstrom Donald A See Remarks | Option exercise · Stock Option (Right to Buy) | −42,242 | 253,456 | ||
| 2021-06-07 | Adams Brian General Counsel | Option exercise | +6,500 | $4.12 | $27K | 32,370 |
| 2021-06-07 | Adams Brian General Counsel | Sale | −6,500 | $35.00 | $228K | 25,870 |
| 2021-06-07 | Adams Brian General Counsel | Option exercise · Stock Option (Right to Buy) | −6,500 | 153,786 | ||
| 2021-06-07 | Catinazzo Thomas Senior Vice President, Finance | Option exercise | +22,500 | $4.12 | $93K | 38,370 |
| 2021-06-07 | Catinazzo Thomas Senior Vice President, Finance | Sale | −22,500 | $35.00 | $788K | 15,870 |
| 2021-06-07 | Catinazzo Thomas Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −22,500 | 84,543 | ||
| 2021-05-19 | Shawver Laura Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 |
Page 23 of 27 · 534 trades